Can Neurofeedback Help Older Adults Sleep?

A forthcoming letter by Shirolapov and Zakharov turns the spotlight toward a clinically important and often frustrating problem: sleep disorders in older adults, with a particular focus on insomnia and the possible role of EEG-based neurofeedback as a non-drug intervention. This is new emerging research with novel insights, although it is worth noting from the start that the paper is a brief narrative letter rather than a full original clinical trial. That distinction matters. The paper does not present newly collected participant data; instead, it synthesizes recent literature and frames neurofeedback as a plausible, increasingly evidence-supported tool for geriatric sleep care.

That is an interesting angle for our field. Older adults are often caught in the therapeutic middle. Pharmacological options can offer short-term symptom relief, but they may also increase fall risk, interact with other medications, worsen daytime sedation, or become difficult to sustain in the setting of polypharmacy. At the same time, first-line behavioral treatments such as cognitive behavioral therapy for insomnia are not always easy to access, especially for patients facing mobility, cost, transportation, or provider-availability barriers. In that context, a non-invasive training-based approach becomes more than scientifically intriguing; it becomes clinically practical.

In general terms, biofeedback refers to training that helps people learn to regulate measurable physiological signals such as heart rate, breathing, muscle tension, or skin conductance through real-time feedback. Neurofeedback is a subtype of biofeedback focused specifically on brain activity, most commonly EEG, with the goal of helping the person gradually self-regulate dysfunctional or inefficient neural patterns.

The central argument of this letter is that sleep disturbance in aging may be especially well-suited to this kind of training. The authors emphasize that neurofeedback may target hyperarousal-related brain dynamics directly, particularly through SMR and iAPF-based approaches. For clinicians and neurofeedback practitioners, that makes this paper less about novelty for novelty’s sake and more about whether sleep in later life may represent one of the clearer, safer, and more scalable applications of EEG self-regulation.

Methods

Because this article is a letter rather than a primary experiment or a fully reported systematic review, its “methods” are better understood as a narrative evidence synthesis than as a conventional research protocol. The authors do not describe a formal search strategy, inclusion and exclusion criteria, preregistration, risk-of-bias assessment, or quantitative meta-analytic procedure. That limitation is important to keep in view. From an evidence-hierarchy standpoint, this is not a standalone dataset and it is not a rigorous review in the strict methodological sense.

What the paper does offer is a concise map of the neurofeedback approaches the authors believe are most relevant for insomnia in older adults. Two protocol families are foregrounded.

The first is sensorimotor rhythm training, generally described here as targeting the 12-15 Hz range. SMR protocols are widely discussed in sleep-related neurofeedback because they have historically been associated with calmer but stable cortical regulation, reduced somatic restlessness, and improvements in sleep continuity in some clinical contexts. The second, and arguably more central, target in this paper is individual alpha peak frequency or iAPF. The authors present iAPF as a biomarker of the balance between cortical activation and relaxation, and they suggest that insomnia is often associated with a shift toward lower alpha peak frequencies, consistent with a persistently activated pre-sleep brain state.

That mechanistic framing is one of the most interesting features of the article. Rather than presenting neurofeedback as a generic relaxation tool, the paper positions it as a method for training a specific dysregulated electrophysiological profile. According to the authors, the therapeutic objective is not simply to make a patient feel sleepy in the moment, but to improve self-regulation of brain rhythms associated with pre-sleep hyperarousal. They also link successful training to stabilization of iAPF and reductions in pathological theta and high-beta activity.

At the same time, the paper leaves several clinically relevant procedural questions unanswered. It does not specify electrode montages, reward and inhibit bands beyond the broad protocol labels, session length, number of sessions, weekly frequency, threshold adjustment strategy, feedback modality, or whether protocols were clinician-guided, semi-automated, or home-based in the studies being discussed. It also blends evidence from clinical trials, reviews, and device feasibility studies without unpacking how these designs differ in quality.

So, from a NeuroBLOG perspective, the methodological takeaway is twofold. First, the article identifies plausible EEG targets for geriatric sleep intervention and ties them to a coherent neurophysiological rationale. Second, it does not provide enough protocol granularity to guide direct clinical replication without consulting the underlying studies it cites. That makes this paper useful as a framing piece and less useful as a protocol manual.

Results

Since the article does not report original patient-level data, its “results” are best read as a summary of what the cited literature collectively suggests. The authors describe a generally favorable evidence pattern for EEG neurofeedback in sleep disturbance, including older adults, with improvements reported in both subjective and objective sleep outcomes.

On the subjective side, the paper highlights reductions in Pittsburgh Sleep Quality Index scores in the range of roughly 25-45%. If those estimates hold up across well-controlled samples, that would represent a clinically meaningful shift in how patients experience their nights: less frustration with sleep onset, less broken sleep, and often a better sense of restoration in the morning. In clinical practice, that matters because sleep treatment is not only about polysomnography; it is also about whether the patient feels more rested, more resilient, and less trapped by the nightly anticipation of another poor night.

The letter also cites objective improvements. It reports decreases in sleep onset latency of about 20-40% and increases in total sleep time of approximately 15-40 minutes, based on prior work using measures such as polysomnography and actigraphy. For older adults, that is not trivial. A modest reduction in the time required to fall asleep can have outsized effects on distress, bedtime avoidance, and learned insomnia behaviors. Likewise, a gain of even 20 or 30 minutes of consolidated sleep may translate into better daytime cognition, mood stability, and fatigue management.

Mechanistically, the authors connect these sleep improvements to successful self-regulation of brain rhythms: stabilization of iAPF and reductions in theta and high-beta power that may reflect lower pre-sleep hyperarousal. That explanation is plausible and consistent with the broader idea that chronic insomnia is not simply a problem of “not being tired enough,” but often a disorder of impaired deactivation. The brain does not smoothly transition into sleep; it keeps a foot on the accelerator.

Still, this results section requires some caution tape. The article does not provide effect sizes from a single pooled analysis, confidence intervals, sample sizes for the outcome estimates it cites, or a breakdown of how many of the underlying studies were truly focused on older adults rather than broader insomnia populations. It also does not deeply examine null findings, sham-controlled contrasts, expectancy effects, or the extent to which symptom improvement might reflect non-specific therapeutic ingredients such as attention, structure, relaxation practice, or clinician contact.

So the most evidence-faithful reading is this: the paper summarizes a promising signal that neurofeedback may improve sleep quality, sleep onset latency, and total sleep time, but the precision and certainty of those estimates remain limited by heterogeneity in the underlying literature and by the brevity of the letter itself.

Discussion

What makes this paper clinically compelling is not that it proves neurofeedback “works” for every older adult with insomnia. It does not do that. What it does, rather effectively, is argue that geriatric sleep medicine may be one of the more sensible places to look for real-world neurofeedback utility.

The first reason is safety. In older adults, treatment decisions rarely happen in a clean laboratory vacuum. They happen in the context of polypharmacy, medication sensitivity, chronic pain, mood symptoms, cardiometabolic disease, and sometimes mild cognitive change. A non-pharmacological intervention that is non-invasive and adaptable already starts with an advantage. That does not make neurofeedback automatically effective, but it does make it clinically attractive. When the alternative is another sedating medication layered onto an already crowded regimen, the threshold for considering a learning-based intervention understandably drops.

The second reason is mechanistic fit. Insomnia in later life is often discussed behaviorally, but the experience many patients describe is one of persistent activation: the body is in bed, but the system is not offline. The authors’ focus on iAPF and pre-sleep hyperarousal is useful because it frames sleep disruption as a regulatory disorder, not merely a symptom cluster. For neurofeedback professionals, that is a familiar conceptual home. We are often working not against a single “disease entity,” but against dysregulated state transitions: difficulty shifting from vigilance to rest, from sympathetic tone to parasympathetic recovery, from cognitive persistence to cognitive quiet.

Third, the paper implicitly opens a conversation about personalization. The authors emphasize the appeal of iAPF-guided training, which fits well with a broader move in neurofeedback away from one-size-fits-all protocols. In practice, that does not mean every case requires maximal technological complexity. It does mean older adults with identical complaints on paper may not present with the same EEG dynamics, the same comorbid anxiety profile, or the same level of physiological arousal. A patient with sleep-maintenance insomnia and evening worry may not need the same training logic as a patient with chronic pain, frequent nocturnal awakening, and daytime cognitive slowing. The promise here is not simply “neurofeedback for insomnia,” but targeted neurofeedback for specific regulatory bottlenecks.

There is also a broader interdisciplinary point worth making. Sleep rarely travels alone in geriatric care. It tends to arrive with anxiety, low mood, fatigue, reduced activity, memory complaints, or caregiver stress. The letter notes that neurofeedback may also ease concomitant symptoms of anxiety and depression. That claim should be handled carefully, because it is not the primary endpoint of the letter and is not unpacked in detail. Still, clinically, it is plausible that improving self-regulation in a sleep-disrupted older adult could produce secondary gains in emotional resilience and daily functioning. Whether those gains are specific to EEG training or partly attributable to the structure of repeated guided sessions remains an open question.

For referring professionals, the practical implication is measured optimism. This paper does not justify replacing first-line insomnia care wholesale. Cognitive behavioral therapy for insomnia remains a crucial standard, and sleep medicine assessment remains essential when apnea, restless legs, circadian dysregulation, medication effects, or neurodegenerative processes are in the differential. But the letter does support the idea that neurofeedback may deserve a seat at the table as an adjunctive or alternative option, especially when medication is poorly tolerated, behavioral therapy is inaccessible, or hyperarousal appears central.

For clients and families, the key message is that neurofeedback is not a magic sleep button. It is more like guided practice for a nervous system that has become too good at staying “on.” Progress is likely to be gradual, dependent on protocol quality, therapeutic context, and individual neurophysiology. That framing protects against both overhype and disappointment.

For neurofeedback practitioners, the paper offers encouragement and a caution. The encouragement is obvious: sleep in older adults may be a meaningful, scalable application with strong face validity and high clinical need. The caution is equally important: the evidence base still needs cleaner trials, better standardization, and stronger geriatric-specific designs. As appealing as the iAPF narrative is, clinicians should resist the temptation to treat every older poor sleeper as a straightforward alpha problem. Sleep complaints can reflect depression, pain, circadian phase shifts, medication effects, trauma, sleep apnea, dementia-related changes, or combinations thereof. Neurofeedback can be part of a serious plan, but not a shortcut around careful assessment.

Finally, the paper gestures toward an especially interesting frontier: the possibility that better sleep regulation in aging could influence downstream pathways related to glymphatic clearance, neurodegenerative risk, and inflammaging. At present, that remains more hypothesis-generating than established. Still, it is a valuable reminder that sleep quality in older adulthood is not just about comfort. It may be tightly linked to cognitive aging, systemic health, and long-term resilience. If neurofeedback can reliably improve that terrain, even modestly, its relevance could extend beyond the bedroom.

Brendan’s Perspective

What I appreciate about this paper is not that it gives us a finished recipe. It does not. What it offers is something more useful for clinicians who actually work with sleep complaints every week: a credible rationale for taking sleep in older adults seriously as a neurofeedback target, while still reminding us that sleep is never just a frequency band and never just a protocol label. In practice, this is where the interesting work begins.

Designing sleep-focused EEG neurofeedback protocols for older adults

If I were translating this paper into practice, I would start with restraint rather than enthusiasm. The temptation in sleep work is to grab the nearest “insomnia protocol” and press go. Older adults deserve better than that. They often bring multiple interacting variables into the room: lighter sleep architecture, medication effects, pain, grief, anxiety, cardiovascular load, and sometimes subtle cognitive change. That means the protocol has to be calming without becoming flattening, and supportive without assuming every brain is dysregulated in the same way.

The two targets highlighted here, SMR and individualized alpha peak frequency, make sense as starting points. SMR training, often approached around 12-15 Hz, has long had practical appeal in sleep-related work because it may support stable, physically settled states without simply sedating the system. In real clinics, many practitioners will think about central or centroparietal sites when exploring SMR-related training, especially when the patient presents with bodily restlessness, sleep-onset difficulty, or a pattern that feels more “can’t switch off” than “can’t stay asleep.” That said, the paper does not hand us a montage, and I think that is healthy. Site selection should follow presentation, recording quality, and broader assessment rather than habit.

The iAPF idea is especially interesting because it nudges us toward precision. Instead of assuming that every poor sleeper needs the same reward band, it suggests we pay attention to the person’s actual alpha dynamics and the broader story they tell about cortical activation and deactivation. I like that move. It is more adult, clinically speaking. It treats the brain as an individual nervous system, not as a worksheet.

Still, I would be cautious about turning iAPF into a new orthodoxy. In clinic, alpha findings can be shaped by fatigue, medication, anxiety, eyes-open versus eyes-closed conditions, and plain old day-to-day variability. A measured approach is better: use the signal as part of a larger formulation, not as a dictator.

When insomnia is not just insomnia

This may be the most important practical point. A large share of “insomnia” referrals are not really about sleep in isolation. Sleep is the symptom that finally becomes intolerable, but the real driver may be chronic hypervigilance, unresolved stress physiology, pain, breathing instability, hormonal shifts, mood disorder, medication rebound, or early neurodegenerative change. The older the client, the less likely it is that a single-cause explanation will be enough.

That matters enormously for protocol choice. A client whose sleep difficulty is driven by evening rumination and autonomic tension may respond differently than a client whose nights are fragmented by pain flares or untreated sleep apnea. Likewise, someone with trauma-related nocturnal activation may need a slower pacing strategy and more attention to safety, interoception, and autonomic settling than someone whose main issue is circadian drift and irregular sleep timing. Neurofeedback can be helpful in both pictures, but not in the same way and not on the same timeline.

This is why I am always a little skeptical when sleep protocols are discussed as though they live outside the rest of the case. They do not. Sleep sits inside the whole person. If the daytime nervous system is overclocked, if the body never feels safe enough to downshift, or if the person is metabolically and emotionally exhausted, the night usually tells on it.

For that reason, one of the best uses of this paper may be as a reminder to widen the assessment lens. Before assuming a straightforward insomnia mechanism, I would want to know about pain, dreams, nocturnal panic, breathing, movement, medication timing, alcohol use, morning fatigue, cognitive complaints, and grief. That is not because neurofeedback is less relevant. It is because the better we understand the sleep complaint, the more intelligently we can use it.

How to individualize treatment beyond the article

If this paper points toward anything, it points toward personalization. And in my view, personalization in neurofeedback is not fancy language for “complicate the case.” It means choosing the simplest intervention that still respects the individuality of the nervous system in front of you.

This is where qEEG, careful clinical interviewing, and session-by-session observation can all earn their keep. I would not say every sleep client requires a full quantitative workup to benefit, but when older adults present with mixed sleep, mood, cognitive, and medical factors, it can be very helpful to know whether we are seeing diffuse slowing, elevated fast activity, alpha irregularities, frontal asymmetry patterns, or simply noisy physiology around an otherwise ordinary sleep complaint. The article’s emphasis on iAPF fits beautifully with this mindset: measure first, then train with intention.

Individualization also means pacing. Some older adults do very well with direct EEG training. Others benefit more when neurofeedback is paired with gentler physiological scaffolding such as breathing training, HRV biofeedback, or body-based settling strategies. I am especially fond of combining sleep-focused neurofeedback with simple autonomic regulation work when the person presents as chronically revved but tired. That combination often makes the training feel less like “trying harder to sleep” and more like teaching the system how to trust rest again.

I would also individualize the dose. Not every older adult needs an aggressive schedule, and not every brain tolerates rapid threshold shifts or strong performance demands. Some clients need shorter sessions, slower progression, and more emphasis on comfort and confidence. In sleep work, forcing intensity is often counterproductive. The nervous system learns best when it is invited rather than cornered.

What this paper means for real clinics

In the real world, this paper supports a very practical stance: neurofeedback deserves consideration as part of an insomnia care pathway for older adults, especially when medications are poorly tolerated, conventional therapy is inaccessible, or the case clearly revolves around hyperarousal. That is a meaningful takeaway. It gives clinicians permission to think of sleep not as a fringe application, but as a central one.

At the same time, real clinics need realism. This paper does not replace sleep medicine. It does not rule out apnea, restless legs, circadian disturbance, depression, or medication effects. It does not tell us that every older adult who sleeps badly should be sent directly to EEG training. But it does suggest that when sleep complaints persist despite reasonable care, neurofeedback may be a very sensible next layer.

For referral networks, that means stronger collaboration. The ideal setup is not neurofeedback versus CBT-I versus medical workup. It is neurofeedback alongside thoughtful sleep assessment, primary care input, psychotherapy when needed, and a willingness to track outcomes honestly. Clinics that do this well will probably be the ones that contribute most meaningfully to the next generation of evidence.

My overall reaction is positive. Sleep in older adults is one of those areas where our field may be especially well positioned to help, provided we stay humble, assess carefully, and avoid pretending that every tired brain needs the same recipe. This paper does not close the case. It opens it in the right direction.

Conclusion

This short paper makes a persuasive case that neurofeedback deserves serious attention in the treatment conversation around sleep disorders in older adults. Its central strengths are not flashy claims, but clinical relevance: aging patients often need non-drug options, sleep complaints are common and costly, and the neurofeedback targets highlighted here are at least conceptually aligned with the hyperarousal model of insomnia. The paper also does a good job of framing geriatric sleep as a promising domain for personalized, non-invasive EEG training.

At the same time, the article should be read with the right amount of scientific restraint. It is a concise narrative letter built on prior studies, not a definitive randomized controlled trial. It does not provide the protocol-level detail or methodological rigor needed to settle the question on its own. What it offers is a thoughtful and encouraging synthesis: enough to justify continued clinical interest, but not enough to skip the hard work of individualized assessment and evidence-aware practice.

That is still good news. In a field where older adults are too often offered either medication or resignation, neurofeedback may represent a third path: careful, personalized training aimed at helping the brain rediscover how to let go into sleep. That is not a small thing. And if future geriatric-focused trials strengthen what this paper begins to outline, this could become one of the most meaningful applied areas in neurofeedback.

References

• Shirolapov, I., & Zakharov, A. (2026). Non-drug therapy for sleep disorders in the elderly: A focus on neurofeedback technology. Aging Pathobiology and Therapeutics, 8(1)

• Recio-Rodriguez, J. I., Fernandez-Crespo, M., Sanchez-Aguadero, N., Gonzalez-Sanchez, J., Garcia-Yu, I., Alonso-Dominguez, R., et al. (2024). Neurofeedback to enhance sleep quality and insomnia: A systematic review and meta-analysis of randomized clinical trials. Frontiers in Neuroscience, 18, 1450163.

• Ribeiro, T., Carriello, M., de Paula, E., Jr., Garcia, A., da Rocha, G., & Teive, H. (2023). Clinical applications of neurofeedback based on sensorimotor rhythm: A systematic review and meta-analysis. Frontiers in Neuroscience, 17, 1195066.

• Van Someren, E. J. W. (2021). Brain mechanisms of insomnia: New perspectives on causes and consequences. Physiological Reviews, 101(3), 995-1046.